EN PL

EMA: Appendix 1 to the guideline on the evaluation of anticancer medicinal products in man

26.01.2012
The use of progression-free survival (PFS) or disease-free survival (DFS) as endpoint in clinical efficacy trials presents several methodological issues which need to be addressed prospectively.